• • 

    

    William D. Tap, MD

    Peer

  • 

    

    Silvia Stacchiotti, MD

    Peer

  • 

    

    Michiel van de Sande, MD, PhD

    Peer

  • 

    

    Andrew J. Wagner, MD, PhD

    Peer

  5

  

  RestartResume

  RestartResume

  Tenosynovial Giant Cell Tumor (TGCT): New Perspectives on Advances in Treatment

• • 

    

    Omid Hamid, MD

    Peer

  • 

    

    Do-Youn Oh, MD, PhD

    Peer

  11

  

  RestartResume

  RestartResume

  Biliary Tract Carcinoma: Are We at the Point of Change?

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Jyoti Patel, MD

    Peer

  • 

    

    Benjamin Levy, MD

    Peer

  7

  

  RestartResume

  RestartResume

  Practical Considerations on the Use of Immune Checkpoint Inhibitors & Chemoth...

• • 

    

    Christine Bestvina, MD

    Peer

  1

  

  RestartResume

  RestartResume

  Getting Ahead of Recurrence in NSCLC

• • 

    

    Christine Bestvina, MD

    Peer

  1

  

  RestartResume

  RestartResume

  Treatment Choices for Non-Small Cell Lung Cancer by Stage

• • 

    

    Alfredo L. Falcone, MD

    Peer

  • 

    

    Sebastian Stintzing, MD

    Peer

  • 

    

    Tianshu Liu, MD

    Peer

  3

  

  RestartResume

  RestartResume

  Considerações Clínicas na Sequenciação do Tratamento do CCRM

Featured

• • 

    

    Scott Kopetz, MD, PhD, FACP

    Peer

  • 

    

    Alberto Sobrero, MD

    Peer

  • 

    

    Rui-Hua Xu, MD

    Peer

  19

  

  RestartResume

  RestartResume

  Improving Clinical Practice in Management of mCRC: A Focus on Tumor Sidedness

• • 

    

    Timothy A. McCarthy, MD

    Peer

  14

  

  RestartResume

  RestartResume

  Precision Oncology: Incorporating Next Generation Sequencing (NGS) in NSCLC

• • 

    

    Edward S. Kim, MD

    Peer

  3

  

  RestartResume

  RestartResume

  The Value of Multidisciplinary Teams in NSCLC Care Plans

• 4

  

  RestartResume

  RestartResume

  Recent Breakthroughs in Head and Neck Cancer

• • 

    

    Tanguy Seiwert, MD

    Peer

  4

  

  RestartResume

  RestartResume

  Current Recommendations: HPV Tumors in Head & Neck Cancers

• • 

    

    Athanassios Argiris, MD, PhD, FACP

    Peer

  2

  

  RestartResume

  RestartResume

  Key Developments within Head & Neck Cancer
• 3

  

  RestartResume

  RestartResume

  Novel Therapies for Head & Neck Cancer
• 3

  

  RestartResume

  RestartResume

  Management of Head & Neck Cancer
• 2

  

  RestartResume

  RestartResume

  Management of Recurrent Squamous Cell Carcinoma of the Head & Neck

• • 

    

    Tanguy Seiwert, MD

    Peer

  4

  

  RestartResume

  RestartResume

  Targeted Therapy for Head & Neck Cancer
• 3

  

  RestartResume

  RestartResume

  Colorectal Cancer Physician Resources